RedChip's  Instablog

Send Message
RedChip's long history of success includes the first to issue independent research coverage on Starbucks in 1992. Other names RedChip discovered as they were on the cusp of becoming Blue-Chip stocks were: Nike™,™, Daktronics™. Over the years, RedChip has evolved into a... More
My company:
RedChip Companies, Inc.
My blog:
Smallcap Ideas
  • Northwest Bio CEO Interviewed On Floor Of New York Stock Exchange 0 comments
    May 7, 2013 12:27 PM | about stocks: NWBO

    NWBO LogoNorthwest Biotherapeutics (NasdaqCM: NWBO) CEO Linda Powers was recently interviewed on the floor of the New York Stock Exchange by Fox Business, the Huffington Post, and the International Business Times.

    In the Fox interview, Ms. Powers described the importance of NW Bio's DCVax cancer immunotherapy platform in mobilizing a patient's whole immune system, and in targeting the full set of biomarkers on the cancer. You can watch the interview at

    In the Huffington Post and New York Financial Press interview, Ms. Powers outlined in more detail the process of creating the DCVax vaccine. She also discussed the significance of key regulatory approvals obtained in the U.S. and Europe, relating to Phase III clinical trials and Phase I/II trials. You can watch the Huffington Post interview at

    In the International Business Times interview, Ms. Powers recounted the cost-saving potential of the DCVax platform, which positions NW Bio well in the face of the rapidly rising costs of less-effective conventional cancer treatments. You can watch the interview at

    NWBO's lead program is a 312-patient Phase III trial to treat glioblastoma multiforme, the most aggressive and lethal form of brain cancer. The Company also previously received clearance from the FDA for a 612-patient Phase III trial in prostate cancer and Phase I/II trials in multiple other cancers. NWBO's cancer therapies have demonstrated the ability to significantly extend patient survival while eliminating the debilitating side effects associated with conventional treatments such as chemotherapy. To learn more about NWBO, watch our "Money Report" interview with CEO Linda Powers.

    Disclosure: The subject security is a client of RedChip Companies, Inc. RedChip Companies, Inc., employees and affiliates may have positions and affect transactions in the securities or options of the issuers mentioned herein. For full financial disclosures for all RedChip clients, please visit

    Stocks: NWBO
Back To RedChip's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.